Lymphomas in persons with AIDS are mostly B-cell types, but T-cell lymphoma
s have also been reported. We examined T-cell lymphoma risk in the 2-year p
eriod after AIDS onset by linking 302,834 adults with AIDS to cancer regist
ry data. Of 6,788 cases of non-Hodgkin's lymphoma (NHL) with specified hist
ologies, 96 (1.4%) were T-cell lymphomas. Assessment was based on clinical
diagnosis and histology because T-cell marker data were inadequate, but whe
n present, marker data supported the T-cell diagnosis. The relative risk of
T-cell lymphoma, estimated by standardized incidence ratio, was 15.0 (95%
confidence interval: 10.0-21.7). Risks were increased for all subtypes, inc
luding mycosis fungoides, peripheral lymphomas, cutaneous lymphomas, and ad
ult T-cell leukemia/lymphoma (ATLL). HIV-related immunodeficiency could be
important, but differences between the population developing AIDS and the g
eneral population (e. g., immigration from the Caribbean region for ATLL) m
ight independently increase T-cell lymphoma risk.